Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

[PR Newswire] – SAN DIEGO, Feb. 26, 2014 /PRNewswire/ — Neurocrine Biosciences, Inc. (NBIX) today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $17.75 per share. The gross pr more

View todays social media effects on NBIX

View the latest stocks trending across Twitter. Click to view dashboard

See who Neurocrine is hiring next, click here to view